New UK funding will help tackle the world’s most pressing health challenges

New UK funding will help achieve UN Sustainable Development Goals by boosting health security and improving health and wellbeing around the world.

Arthritis-style immunotherapy shows promise for heart failure

A study uncovers IL-1β signaling in cardiac fibrosis, highlighting distinct fibroblast populations and promising immunotherapy strategies for heart failure.

October 24, 2024

Anti-VEGF Ocular Implant for Age-Related Macular Degeneration to Return to Market

The ranibizumab ocular implant (Susvimo) for neovascular (wet) age-related macular degeneration (nAMD) will return to the U.S. market “in the coming weeks,” Genentech announced. The

July 9, 2024

Bold Secures $17M to Expand Healthy Aging Platform with Medicare Plans

What You Should Know: Bold, a Los Angeles-based healthy aging platform raises $17M in Series A funding led by Rethink Impact, with participation from Samsung

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.